Dividend Channel
Market News Video Dividend Detective The Warren Buffetts Next Door Stock message boards
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

Interesting ACAD Put And Call Options For March 29th
Thursday, February 8, 12:00 PM ET, by Market News Video Staff

Investors in Acadia Pharmaceuticals Inc (ACAD) saw new options begin trading today, for the March ...

Clovis Oncology Enters Oversold Territory (CLVS)
Thursday, February 8, 12:29 PM ET, by Market News Video Staff

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...

ETF Flows Report for 02/13/2018
Tuesday, February 13, 10:51 AM ET, by Market News Video Staff

.porttr { font-family: Arial; font-size: 12pt; font-weight: bold; height: 24px; } .porttd1 { font-family: Arial; ...

Interesting ACAD Put And Call Options For April 20th
Wednesday, February 14, 10:41 AM ET, by Market News Video Staff

Investors in Acadia Pharmaceuticals Inc (ACAD) saw new options become available today, for the April ...

XBI, BIVV, JUNO, MDXG: Large Inflows Detected at ETF
Wednesday, February 14, 10:52 AM ET, by Market News Video Staff

Symbols mentioned in this story: XBI, BIVV, JUNO, MDXG Exchange traded funds (ETFs) trade just ...

Investors Grab ACAD 47.8% Cheaper Than Its Secondary Stock Offering

By Dividend Channel Staff, Thursday, April 7, 11:20 AM ET
Play Video: The Importance of ETFs

If the video does not load after a few moments, Upgrade to the Latest Flash Player.

Looking back to 92 days ago, Acadia Pharmaceuticals Inc (NASDAQ:ACAD) priced a 10,000,000 share secondary stock offering at $61.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time. In trading on Thursday, bargain hunters could buy shares of ACAD and achieve a cost basis 47.8% cheaper than those buyers, with shares changing hands as low as $31.86 per share.

Secondaries can often present buying opportunities for bullish investors interested in purchasing shares, because the sudden extra supply of stock tends to require that the offering be priced at an attractive discount to where the stock had previously been trading before the offering announcement. At last check, Acadia Pharmaceuticals Inc shares are currently trading down about 2.7% on the day. The chart below shows the one year performance of ACAD shares, versus its 200 day moving average:

Acadia Pharmaceuticals Inc Chart

Looking at the chart above, ACAD's low point in its 52 week range is $16.64 per share, with $51.99 as the 52 week high point that compares with a last trade of $31.99.

According to the ETF Finder at ETF Channel, ACAD makes up 3.05% of the SPDR S&P Biotech ETF (AMEX:XBI) which is trading lower by about 2.2% on the day Thursday.

See what other ETFs contain ACAD
See what other stocks are held by XBI

Special Offer: Try OLI Premium and get reports on Splits, Buybacks, and M&A daily

This Article's Word Cloud:   ACAD   AMEX   Acadia   According   Biotech   Buybacks   Buyers   Channel   ETFs   Finder   Looking   Offer   Offerings   Pharmaceuticals   Premium   Recent   SPDR   Secondaries   Secondary   Special   Splits   Start   Stock   Thursday   about   above   achieve   announcement   attractive   average   back   bargain   basis   because   been   chart   investment   last   offering   other   point   priced   share   shares   stock   that   trading   week   what   with

Investors Grab ACAD 47.8% Cheaper Than Its Secondary Stock Offering | www.DividendChannel.com | Copyright © 2010 - 2018, All Rights Reserved

Nothing in Dividend Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and dividend videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Dividend Channel; Meet Our Editorial Staff.